Pfizer and KRIBB jointly to research for cancer drugs.

Published: 2007-06-19 06:57:00

Updated: 2007-06-19 06:57:00

Pfizer and Korea Research Institute of Bioscience and Biotechnology (KRIBB) have made an MOU agreement for a joint research collaboration of the new therapeutic drugs in the area of liver and stomach cancer in the morning of June 14 in attendance of Chairman Jeff Kindler and other officers from t...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK